======= ADTRP ======= == Gene Information == * **Official Symbol**: ADTRP * **Official Name**: androgen dependent TFPI regulating protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84830|84830]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96IZ2|Q96IZ2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ADTRP&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ADTRP|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614348|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Regulates the expression and the cell-associated anticoagulant activity of the inhibitor TFPI in endothelial cells (in vitro). {ECO:0000269|PubMed:21868574}. |Far-17a AIG1| |negative regulation of extracellular matrix constituent secretion| |regulation of extracellular matrix constituent secretion| |long-chain fatty acid catabolic process| |cellular response to oxidised low-density lipoprotein particle stimulus| |negative regulation of extracellular matrix organization| |negative regulation of lymphocyte migration| |cell migration involved in sprouting angiogenesis| |response to lipoprotein particle| |cellular response to lipoprotein particle stimulus| |blood vessel endothelial cell migration| |protein kinase B signaling| |regulation of extracellular matrix organization| |negative regulation of leukocyte migration| |negative regulation of blood coagulation| |negative regulation of hemostasis| |negative regulation of coagulation| |sprouting angiogenesis| |regulation of lymphocyte migration| |endothelial cell migration| |negative regulation of wound healing| |caveola| |hydrolase activity| |regulation of blood coagulation| |regulation of hemostasis| |regulation of coagulation| |epithelial cell migration| |negative regulation of response to wounding| |epithelium migration| |tissue migration| |fatty acid catabolic process| |long-chain fatty acid metabolic process| |monocarboxylic acid catabolic process| |negative regulation of leukocyte cell-cell adhesion| |negative regulation of protein secretion| |regulation of wound healing| |negative regulation of peptide secretion| |regulation of response to wounding| |ameboidal-type cell migration| |negative regulation of cell-cell adhesion| |negative regulation of protein transport| |negative regulation of establishment of protein localization| |cellular response to steroid hormone stimulus| |cellular lipid catabolic process| |regulation of leukocyte migration| |negative regulation of secretion by cell| |negative regulation of secretion| |negative regulation of cell migration| |carboxylic acid catabolic process| |organic acid catabolic process| |negative regulation of cell adhesion| |negative regulation of cell motility| |regulation of leukocyte cell-cell adhesion| |lipid catabolic process| |negative regulation of cellular component movement| |angiogenesis| |negative regulation of locomotion| |fatty acid metabolic process| |response to steroid hormone| |negative regulation of response to external stimulus| |regulation of cell-cell adhesion| |blood vessel morphogenesis| |small molecule catabolic process| |negative regulation of immune system process| |regulation of protein secretion| |negative regulation of transport| |blood vessel development| |regulation of peptide secretion| |regulation of body fluid levels| |vasculature development| |cardiovascular system development| |cellular response to lipid| |monocarboxylic acid metabolic process| |cellular response to organic cyclic compound| |cellular response to hormone stimulus| |cell surface| |tube morphogenesis| |regulation of cell adhesion| |negative regulation of cellular component organization| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |regulation of secretion| |tube development| |regulation of cell migration| |response to lipid| |circulatory system development| |anatomical structure formation involved in morphogenesis| |carboxylic acid metabolic process| |response to hormone| |regulation of cell motility| |response to organic cyclic compound| |cellular lipid metabolic process| |cell migration| |regulation of locomotion| |regulation of cellular component movement| |response to organonitrogen compound| |oxoacid metabolic process| |positive regulation of protein phosphorylation| |organic acid metabolic process| |regulation of protein localization| |positive regulation of phosphorylation| |localization of cell| |cell motility| |response to nitrogen compound| |regulation of response to external stimulus| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |negative regulation of multicellular organismal process| |lipid metabolic process| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |locomotion| |regulation of protein phosphorylation| |response to endogenous stimulus| |regulation of response to stress| |movement of cell or subcellular component| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |negative regulation of response to stimulus| |regulation of immune system process| |intracellular signal transduction| |positive regulation of protein metabolic process| |small molecule metabolic process| |organic substance catabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |cellular catabolic process| |regulation of protein modification process| |regulation of transport| |positive regulation of gene expression| |membrane| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18561 * **Expression level (log2 read counts)**: 0.56 {{:chemogenomics:nalm6 dist.png?nolink |}}